Found 24 results
↓ CSVName | Type of Offering | Accepted Date |
---|---|---|
Virion Therapeutics, LLC
See All Filings
|
D/A | 2020-10-20 09:55:13 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-20-000007
Exclusions or Exemptions
506b
Accepted Date
2020-10-20 09:55:13
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Debt
|
||
Virion Therapeutics, LLC
See All Filings
|
D/A | 2021-05-13 17:06:08 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-21-000005
Exclusions or Exemptions
506b
Accepted Date
2021-05-13 17:06:08
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Debt
|
||
Virion Therapeutics, LLC
See All Filings
|
D/A | 2020-03-18 15:39:39 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-20-000002
Exclusions or Exemptions
506b
Accepted Date
2020-03-18 15:39:39
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Debt
|
||
Virion Therapeutics, LLC
See All Filings
|
D/A | 2018-09-04 14:37:47 |
Amount To Be Raised
$5,500,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-18-000004
Exclusions or Exemptions
506b
Accepted Date
2018-09-04 14:37:47
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Equity
|
||
Virion Therapeutics, LLC
See All Filings
|
D/A | 2018-09-21 14:53:17 |
Amount To Be Raised
$5,500,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-18-000005
Exclusions or Exemptions
506b
Accepted Date
2018-09-21 14:53:17
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Equity
|
||
Virion Therapeutics, LLC
See All Filings
|
D/A | 2020-05-19 17:34:32 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-20-000003
Exclusions or Exemptions
506b
Accepted Date
2020-05-19 17:34:32
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Debt
|
||
Virion Therapeutics, LLC
See All Filings
|
D/A | 2021-01-04 15:23:54 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-21-000001
Exclusions or Exemptions
506b
Accepted Date
2021-01-04 15:23:54
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Debt
|
||
Virion Therapeutics, LLC
See All Filings
|
D/A | 2020-11-05 14:36:37 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-20-000008
Exclusions or Exemptions
506b
Accepted Date
2020-11-05 14:36:37
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Debt
|
||
Virion Therapeutics, LLC
See All Filings
|
D/A | 2021-06-07 17:59:42 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-21-000006
Exclusions or Exemptions
506b
Accepted Date
2021-06-07 17:59:42
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Debt
|
||
Virion Therapeutics, LLC
See All Filings
|
D/A | 2018-08-01 17:31:48 |
Amount To Be Raised
$5,500,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-18-000003
Exclusions or Exemptions
506b
Accepted Date
2018-08-01 17:31:48
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Equity
|
||
Virion Therapeutics, LLC
See All Filings
|
D/A | 2020-09-17 16:32:48 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-20-000006
Exclusions or Exemptions
506b
Accepted Date
2020-09-17 16:32:48
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Debt
|
||
Virion Therapeutics, LLC
See All Filings
|
D/A | 2021-03-12 11:56:02 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-21-000004
Exclusions or Exemptions
506b
Accepted Date
2021-03-12 11:56:02
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Debt
|
||
Virion Therapeutics, LLC
See All Filings
|
D/A | 2020-01-06 12:51:08 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-20-000001
Exclusions or Exemptions
506b
Accepted Date
2020-01-06 12:51:08
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Debt
|
||
Virion Therapeutics, LLC
See All Filings
|
D/A | 2021-10-06 17:42:36 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-21-000009
Exclusions or Exemptions
506b
Accepted Date
2021-10-06 17:42:36
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Debt
|
||
Virion Therapeutics, LLC
See All Filings
|
D/A | 2018-07-24 17:24:21 |
Amount To Be Raised
$5,500,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-18-000002
Exclusions or Exemptions
506b
Accepted Date
2018-07-24 17:24:21
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Equity
|
||
Virion Therapeutics, LLC
See All Filings
|
D/A | 2021-02-24 14:32:28 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-21-000003
Exclusions or Exemptions
506b
Accepted Date
2021-02-24 14:32:28
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Debt
|
||
Virion Therapeutics, LLC
See All Filings
|
D/A | 2020-08-13 15:59:34 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-20-000005
Exclusions or Exemptions
506b
Accepted Date
2020-08-13 15:59:34
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Debt
|
||
Virion Therapeutics, LLC
See All Filings
|
D/A | 2021-08-25 17:17:04 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-21-000008
Exclusions or Exemptions
506b
Accepted Date
2021-08-25 17:17:04
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Debt
|
||
Virion Therapeutics, LLC
See All Filings
|
D/A | 2018-11-27 16:03:41 |
Amount To Be Raised
$5,500,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-18-000007
Exclusions or Exemptions
506b
Accepted Date
2018-11-27 16:03:41
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Equity
|
||
Virion Therapeutics, LLC
See All Filings
|
D | 2018-07-19 17:19:05 |
Amount To Be Raised
$5,500,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-18-000001
Exclusions or Exemptions
506b
Accepted Date
2018-07-19 17:19:05
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Equity
|
||
Virion Therapeutics, LLC
See All Filings
|
D/A | 2021-01-20 18:03:06 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-21-000002
Exclusions or Exemptions
506b
Accepted Date
2021-01-20 18:03:06
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Debt
|
||
Virion Therapeutics, LLC
See All Filings
|
D/A | 2020-07-28 10:17:37 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-20-000004
Exclusions or Exemptions
506b
Accepted Date
2020-07-28 10:17:37
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Debt
|
||
Virion Therapeutics, LLC
See All Filings
|
D | 2019-11-04 11:55:25 |
Amount To Be Raised
$6,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-19-000001
Exclusions or Exemptions
506b
Accepted Date
2019-11-04 11:55:25
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Debt
|
||
Virion Therapeutics, LLC
See All Filings
|
D/A | 2018-10-09 14:56:03 |
Amount To Be Raised
$5,500,000
Associated Brokers / Dealers
N/A
CIK Number
0001746726
Filed Document
0001746726-18-000006
Exclusions or Exemptions
506b
Accepted Date
2018-10-09 14:56:03
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DELAWARE
Revenue or Assets
No Revenues
Type of Security
Equity
|